NCT01981941View on ClinicalTrials.gov

Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 5, 2013

Primary Completion Date

May 13, 2015

Study Completion Date

May 13, 2015

Conditions
Restless Legs Syndrome (RLS)
Interventions
DRUG

Gabapentin enacarbil

Oral

Trial Locations (5)

Unknown

Chugoku

Chūbu

Kansai

Kanto

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY